The results of a recent study involving a neuroprosthetic device, The Argus II, brings hope to blind patients in helping them see objects, color and movement.
The device has been developed by researchers at the company Second Sight, and uses a small camera on a pair of glasses, along with a portable processor and a microchip which transfers information to the retina via implanted electrodes. The device is mainly targeted to treat people who are victims of retinitis pigmentosa (RP).
As part of the study, Lauritzen and his team of researchers streamed patterns of braille directly on to a blind male patient's retina, enabling him to read four-letter words easily without taking much time.
This breakthrough will positively impact future products and treatments for the blind. This product is currently in the process of clinical trials, and there are several research projects which are going on for improvements of the device.